Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe’s capital, Harare.

Black gay men face major PrEP access gaps due to cost, stigma, mistrust, and provider silence—despite high HIV impact; ...

The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday ...

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...

HUNTSVILLE, AL (WAFF) - Sept. 18 marks National HIV/AIDS and Aging Awareness Day. Older Americans are more likely than younger Americans to be diagnosed with HIV infection late in the course of their ...

By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...

Zimbabwe launches lenacapavir, a long-acting HIV prevention drug, aiming to reduce new infections among high-risk groups with ...

Florida's state-funded HIV drug assistance program is facing a significant rollback, impacting drug availability and ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...